Why Amarin Stock Was Rocketing Higher on Wednesday

There was unambigously good news about the company's single commercialized medication.Any one-product company that receives good news about that product will likely attract investors. That was the case Wednesday with Amarin (AMRN 7.07%), which received very encouraging news about its single commercialized drug that day. As a result, its shares were trading more than 6% higher in late-session trading on the stock market, eclipsing the basically flatlining S&P 500 index.A victory for VazkepaAmarin announced t ...